Endothelial dysfunction in children with type 1 diabetes mellitus

Mariapina Pomilio1, Angelika Mohn, Alberto Verrotti

  • 1Clinica Pediatrica, University of Chieti, Italy.

Insights

Endothelial dysfunction, a loss of normal cell properties, is linked to diabetic vascular complications. Impaired vasodilatation is a sensitive marker in type 1 diabetes mellitus patients.

Area of Science:

  • Vascular Biology
  • Endocrinology
  • Diabetology

Background:

  • Endothelial dysfunction involves the loss of normal endothelium functions, impacting vascular tone, permeability, and coagulation.
  • Unbalanced glycaemic control in type 1 diabetes mellitus (DM) significantly affects the endothelium, contributing to vascular complications.
  • Endothelial cell activation markers and impaired endothelium-dependent vasodilatation are observed in young type 1 DM patients.

Purpose of the Study:

  • To investigate the role of endothelial dysfunction in the pathogenesis of vascular complications in type 1 DM.
  • To identify sensitive markers for early endothelial involvement in diabetic patients.
  • To understand the pathophysiological mechanisms linking hyperglycemia to endothelial dysfunction.

Main Methods:

  • Assessing endothelium-derived regulatory proteins, such as von Willebrand factor (vWF) and tissue plasminogen activator (t-PA).
  • Evaluating endothelium-dependent vasodilatation as a marker of endothelial function.
  • Analyzing the impact of hyperglycemia on endothelial cell functions and metabolic pathways.

Main Results:

  • Endothelial dysfunction is characterized by altered protein synthesis, increased vascular tone/permeability, and prothrombotic/antifibrinolytic properties.
  • Abnormal markers of endothelial activation and impaired endothelium-dependent vasodilatation are evident in young type 1 DM patients.
  • Hyperglycemia directly or indirectly alters endothelium functions through various metabolic pathways.

Conclusions:

  • Endothelial dysfunction is a critical factor in diabetic vascular complications, particularly in type 1 DM.
  • Impaired endothelium-dependent vasodilatation may serve as a more sensitive indicator of early endothelial damage than specific protein markers.
  • A comprehensive understanding of endothelial dysfunction pathophysiology is crucial for developing timely therapeutic interventions to prevent or slow diabetic complications.

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...